08045800513
cmd@solitairegroup.in
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations
Glimperide & Metformin Combinations

Glimperide & Metformin Combinations

MOQ : 15-30 Boxes

Glimperide & Metformin Combinations Specification

  • Drug Type
  • Specific Drug
  • Ingredients
  • Glimepride 2 mg + Pioglitazone 30 mg (SR)
  • Physical Form
  • Tablets
  • Function
  • Other
  • Recommended For
  • Management of Type 2 diabetes (NIDDM)
 

Glimperide & Metformin Combinations Trade Information

  • Minimum Order Quantity
  • 15-30 Boxes
  • Payment Terms
  • Cheque, Western Union, Paypal, Cash Advance (CA), Cash in Advance (CID)
  • Sample Policy
  • Sample costs shipping and taxes has to be paid by the buyer
  • Packaging Details
  • Blister Pack, 20 X 10= 200 TABS
  • Main Domestic Market
  • All India
  • Certifications
  • WHO-GMP
 

About Glimperide & Metformin Combinations



Glimperide & Metformin Combinations are formulated to aid in the effective management of Type 2 diabetes mellitus (NIDDM). The tablets combine two potent active ingredients: Glimperide, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin, a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Available in multiple formulations tailored to varying medical needs, Euroglip-M1 contains Glimperide 1 mg and Metformin 500 mg, Euroglip-M2 incorporates Glimperide 2 mg and Metformin 500 mg, and Euroglip-Plus M2 delivers Glimperide 2 mg and Metformin 1000 mg. These tablets are manufactured for adults and aged persons, ensuring precise and reliable performance for diabetes management. Designed for export, these specific drug products meet stringent quality standards suitable for both patients and healthcare providers.

FAQs of Glimperide & Metformin Combinations:


Q: What are Glimperide & Metformin Combinations used for?

A: They are used for managing Type 2 diabetes mellitus (NIDDM).

Q: Who is this medication suitable for?

A: It is suitable for adults and aged persons.

Q: What active ingredients do these tablets contain?

A: They contain Glimperide (1 mg or 2 mg) and Metformin (500 mg or 1000 mg) depending on the formulation.

Q: How does Glimperide & Metformin work?

A: Glimperide stimulates insulin release, while Metformin improves insulin sensitivity and reduces glucose production in the liver.

Q: Are these products available for export?

A: Yes, these products are manufactured and supplied for export.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Diabetic Tablets Category

Metformin 500 mg & 1000 mg (Sustained Release)

Metformin 500 mg & 1000 mg (Sustained Release)

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form : Tablets

Function : Other

Recommended For : Type 2 Diabetes Mellitus

Pioglitazone 15 Mg & Metformin 500 Mg Tablets

Pioglitazone 15 Mg & Metformin 500 Mg Tablets

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form : Tablets

Function : Other

Recommended For : Type 2 Diabetes

Gliclazide 80 Mg & Metformin 500 Mg

Gliclazide 80 Mg & Metformin 500 Mg

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form : Tablets

Function : Other

Recommended For : Type 2 diabetes

Voglibose 0.3 mg & Metformin 500 mg (SR)

Voglibose 0.3 mg & Metformin 500 mg (SR)

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form : Tablets

Function : Other

Recommended For : Type II Diabetes



Back to top